KATHRYN HARSHMAN: Open Payments
NPI 1952537706 · OLYMPIA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,771 in 66 payments from 15 companies in 2025. Trend: 2023 $22 · 2024 $670 · 2025 $1,771
Food & beverage: $1,771
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 10 | $413 |
| ABBVIE INC. | 20 | $345 |
| Phathom Pharmaceuticals, Inc. | 5 | $221 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $156 |
| Alkermes, Inc. | 5 | $106 |
| Lundbeck LLC | 3 | $93 |
| Otsuka America Pharmaceutical, Inc. | 3 | $88 |
| Novo Nordisk Inc | 4 | $84 |
| Exact Sciences Corporation | 4 | $78 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $52 |
Products named: Korlym, QULIPTA, VOQUEZNA, REXULTI, CAPLYTA, VIVITROL, VRAYLAR, Cologuard Collection Kit.
Industry payments across WA — which companies pay providers there.
